Skip to main content
. 2018 Mar 5;96(1):29–56. doi: 10.1111/1468-0009.12311

Table A3.

Diagnosis and Treatment of Depression and Mental Health Conditionsa

All Survey Respondents With Prelottery Diagnosis of Depression Without Prelottery Diagnosis of Depression
Control Mean Effect of Medicaid Coverage p‐Value Control Mean Effect of Medicaid Coverage p‐Value Control Mean Effect of Medicaid Coverage p‐Value p‐Value for Difference Between (7) and (11)
(1) (2) (3) (4) (5) (6) (7) (8) (9) (10)
Diagnosis of depression
Postlottery diagnosis of depression (%) N/A N/A 7.39 5.50 0.049
(2.79)
Undiagnosed depression (%) N/A N/A 14.01 −6.76 0.047
(3.40)
Treatment
Talk therapy (%) N/A 37.4 8.83 0.196 N/A
(6.84)
Prescription medications
Any mental health medication (%)b 20.7 8.77 0.008 44.8 14.53 0.041 7.7 7.58 0.005 0.362
(3.33) (7.10) (2.67)
Mental health medications (#)b 0.335 0.14 0.025 0.771 0.28 0.077 0.099 0.11 0.004 0.301
(0.77) (0.06) (1.07) (0.16) (0.38) (0.04)
Share using any (%):
Antidepressantc 16.8 5.49 0.071 37.5 9.87 0.152 5.7 4.76 0.033 0.484
(3.04) (6.88) (2.23)
SSRI 9.8 4.13 0.088 22.6 8.45 0.157 2.9 2.96 0.069 0.376
(2.42) (5.96) (1.62)
Tricyclic, MAOI, or Other 7.0 3.66 0.082 15.8 6.32 0.227 2.3 2.87 0.051 0.529
(2.10) (5.23) (1.47)
Trazodone 3.4 −0.46 0.747 7.4 −2.70 0.457 1.2 0.96 0.342 0.329
(1.42) (3.62) (1.01)
Anxiolytic 6.2 2.60 0.207 14.1 7.11 0.171 2.0 0.81 0.553 0.242
(2.06) (5.20) (1.37)
Bipolar 5.5 0.39 0.834 12.8 1.89 0.690 1.5 −0.77 0.523 0.584
(1.85) (4.73) (1.21)
Sedative 2.9 4.13 0.004 6.1 6.95 0.045 1.2 2.94 0.013 0.274
(1.43) (3.47) (1.18)
Antipsychotic 4.0 0.80 0.629 9.8 −0.61 0.887 0.8 1.81 0.075 0.582
(1.64) (4.28) (1.02)
Untreated depression (%)d 16.6 −10.50 0.001 20.1 −17.00 0.003 14.8 −6.80 0.053 0.128
(3.05) (5.74) (3.50)
Unmet need for mental health care (%) 24.41 −9.21 0.005 45.82 −12.31 0.071 12.87 −6.19 0.041 0.438
(3.29) (6.82) (3.03)
a

For each sample, the first column reports the control mean of the dependent variable (with standard deviation for continuous outcomes in parentheses). The second column reports the estimated local average treatment effect of Medicaid coverage (with standard error in parentheses). See Appendix for estimating equation. All regressions include indicators for the number of household members on the lottery list and adjust standard errors for household clusters. The final column reports the p‐value for a test for treatment effect heterogeneity by prelottery diagnosis of depression. All analysis is weighted using survey weights. Samples consist of all in‐person interview respondents (n = 12,229), those with a pre‐lottery diagnosis of depression (n = 4,166) and those without (n = 8,063).

b

Trazodone and branded equivalents are excluded from these summary measures.

c

Aggregate result for all survey respondents previously reported in Baicker et al 2013.8

d

This analysis was not prespecified.